|
|
Previous Article | Table of Contents | Next Article 
Blood, 15 April 2002, Vol. 99, No. 8, pp. 2786-2793
HEMATOPOIESIS
Hematopoietic cells expressing the peripheral cannabinoid
receptor migrate in response to the endocannabinoid
2-arachidonoylglycerol
Meritxell Alberich Jordà,
Sandra E. Verbakel,
Peter
J. M. Valk,
Yolanda V. Vankan-Berkhoudt,
Mauro Maccarrone,
Allessandro Finazzi-Agrò,
Bob Löwenberg, and
Ruud Delwel
From the Institute for Hematology, Erasmus University
Rotterdam, The Netherlands; and Department of Experimental Medicine and
Biochemical Sciences, University of Rome "Tor Vergata," Rome,
Italy.
Cb2 is a novel protooncogene encoding the peripheral
cannabinoid receptor. Previous studies demonstrated that 2 distinct
noncoding first exons exist: exon-1A and exon-1B, which both splice to
protein-coding exon-2. We demonstrate that in retrovirally induced
murine myeloid leukemia cells with proviral insertion in
Cb2, exon-1B/exon-2 Cb2 messenger RNA levels
have been increased, resulting in high receptor numbers. In myeloid
leukemia cells without virus insertion in this locus, low levels of
only exon-1A/exon-2 Cb2 transcripts were present and
receptors could not be detected. To elucidate the function of Cb2 in
myeloid leukemia cells, a set of in vitro experiments was carried out
using 32D/G-CSF-R (granulocyte colony-stimulating factor receptor)
cells transfected with exon-1B/exon-2 Cb2 complementary DNA
and a myeloid cell line carrying a virus insertion in Cb2 (ie, NFS 78). We demonstrate that a major function of the Cb2 receptor
is stimulation of migration as determined in a transwell assay.
Exposure of Cb2-expressing cells to different cannabinoids showed that
the true ligand for Cb2 is 2-arachidonoylglycerol (2-AG), which may act
as chemoatractant and as a chemokinetic agent. Furthermore, we observed
a significant synergistic activity between 2-AG and interleukin-3 or
G-CSF, suggesting cross-talk between the different receptor systems.
Radioactive-ligand binding studies revealed significant numbers of Cb2
receptors in normal spleen. Transwell experiments carried out with
normal mouse spleen cells showed 2-AG-induced migration of B220-,
CD19-, immunoglobulin M-, and immunoglobulin D-expressing B
lymphocytes. Our study demonstrates that a major function of Cb2
receptor expressed on myeloid leukemia cells or normal splenocytes is
stimulation of migration.

CiteULike Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
M. Bifulco, A. M. Malfitano, S. Pisanti, and C. Laezza
Endocannabinoids in endocrine and related tumours
Endocr. Relat. Cancer,
June 1, 2008;
15(2):
391 - 408.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. McHugh, C. Tanner, R. Mechoulam, R. G. Pertwee, and R. A. Ross
Inhibition of Human Neutrophil Chemotaxis by Endogenous Cannabinoids and Phytocannabinoids: Evidence for a Site Distinct from CB1 and CB2
Mol. Pharmacol.,
February 1, 2008;
73(2):
441 - 450.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
F. He, Z.-H. Qiao, J. Cai, W. Pierce, D.-C. He, and Z.-H. Song
Involvement of the 90-kDa Heat Shock Protein (Hsp-90) in CB2 Cannabinoid Receptor-Mediated Cell Migration: A New Role of Hsp-90 in Migration Signaling of a G Protein-Coupled Receptor
Mol. Pharmacol.,
November 1, 2007;
72(5):
1289 - 1300.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Oka, J. Wakui, S. Ikeda, S. Yanagimoto, S. Kishimoto, M. Gokoh, M. Nasui, and T. Sugiura
Involvement of the Cannabinoid CB2 Receptor and Its Endogenous Ligand 2-Arachidonoylglycerol in Oxazolone-Induced Contact Dermatitis in Mice
J. Immunol.,
December 15, 2006;
177(12):
8796 - 8805.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. Kurihara, Y. Tohyama, S. Matsusaka, H. Naruse, E. Kinoshita, T. Tsujioka, Y. Katsumata, and H. Yamamura
Effects of Peripheral Cannabinoid Receptor Ligands on Motility and Polarization in Neutrophil-like HL60 Cells and Human Neutrophils
J. Biol. Chem.,
May 5, 2006;
281(18):
12908 - 12918.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. A. Lunn, J. S. Fine, A. Rojas-Triana, J. V. Jackson, X. Fan, T. T. Kung, W. Gonsiorek, M. A. Schwarz, B. Lavey, J. A. Kozlowski, et al.
A Novel Cannabinoid Peripheral Cannabinoid Receptor-Selective Inverse Agonist Blocks Leukocyte Recruitment in Vivo
J. Pharmacol. Exp. Ther.,
February 1, 2006;
316(2):
780 - 788.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. L. Shoemaker, M. B. Ruckle, P. R. Mayeux, and P. L. Prather
Agonist-Directed Trafficking of Response by Endocannabinoids Acting at CB2 Receptors
J. Pharmacol. Exp. Ther.,
November 1, 2005;
315(2):
828 - 838.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Oka, S. Yanagimoto, S. Ikeda, M. Gokoh, S. Kishimoto, K. Waku, Y. Ishima, and T. Sugiura
Evidence for the Involvement of the Cannabinoid CB2 Receptor and Its Endogenous Ligand 2-Arachidonoylglycerol in 12-O-Tetradecanoylphorbol-13-acetate-induced Acute Inflammation in Mouse Ear
J. Biol. Chem.,
May 6, 2005;
280(18):
18488 - 18497.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
P. Gaines, J. Chi, and N. Berliner
Heterogeneity of functional responses in differentiated myeloid cell lines reveals EPRO cells as a valid model of murine neutrophil functional activation
J. Leukoc. Biol.,
May 1, 2005;
77(5):
669 - 679.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Kishimoto, M. Muramatsu, M. Gokoh, S. Oka, K. Waku, and T. Sugiura
Endogenous Cannabinoid Receptor Ligand Induces the Migration of Human Natural Killer Cells
J. Biochem.,
February 1, 2005;
137(2):
217 - 223.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. Nithipatikom, M. P. Endsley, M. A. Isbell, J. R. Falck, Y. Iwamoto, C. J. Hillard, and W. B. Campbell
2-Arachidonoylglycerol: A Novel Inhibitor of Androgen-Independent Prostate Cancer Cell Invasion
Cancer Res.,
December 15, 2004;
64(24):
8826 - 8830.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Oka, S. Ikeda, S. Kishimoto, M. Gokoh, S. Yanagimoto, K. Waku, and T. Sugiura
2-Arachidonoylglycerol, an endogenous cannabinoid receptor ligand, induces the migration of EoL-1 human eosinophilic leukemia cells and human peripheral blood eosinophils
J. Leukoc. Biol.,
November 1, 2004;
76(5):
1002 - 1009.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
P. Casellas
CB2, a paradigm for a novel class of "onco-GPCRs"?
Blood,
July 15, 2004;
104(2):
302 - 303.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Alberich Jorda, N. Rayman, M. Tas, S. E. Verbakel, N. Battista, K. van Lom, B. Lowenberg, M. Maccarrone, and R. Delwel
The peripheral cannabinoid receptor Cb2, frequently expressed on AML blasts, either induces a neutrophilic differentiation block or confers abnormal migration properties in a ligand-dependent manner
Blood,
July 15, 2004;
104(2):
526 - 534.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Kishimoto, Y. Kobayashi, S. Oka, M. Gokoh, K. Waku, and T. Sugiura
2-Arachidonoylglycerol, an Endogenous Cannabinoid Receptor Ligand, Induces Accelerated Production of Chemokines in HL-60 Cells
J. Biochem.,
April 1, 2004;
135(4):
517 - 524.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
N. Rayman, K. H. Lam, J. D. Laman, P. J. Simons, B. Lowenberg, P. Sonneveld, and R. Delwel
Distinct Expression Profiles of the Peripheral Cannabinoid Receptor in Lymphoid Tissues Depending on Receptor Activation Status
J. Immunol.,
February 15, 2004;
172(4):
2111 - 2117.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T. W. Klein, C. Newton, K. Larsen, L. Lu, I. Perkins, L. Nong, and H. Friedman
The cannabinoid system and immune modulation
J. Leukoc. Biol.,
October 1, 2003;
74(4):
486 - 496.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Kishimoto, M. Gokoh, S. Oka, M. Muramatsu, T. Kajiwara, K. Waku, and T. Sugiura
2-Arachidonoylglycerol Induces the Migration of HL-60 Cells Differentiated into Macrophage-like Cells and Human Peripheral Blood Monocytes through the Cannabinoid CB2 Receptor-dependent Mechanism
J. Biol. Chem.,
June 27, 2003;
278(27):
24469 - 24475.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. A. Jorda, B. Lowenberg, and R. Delwel
The peripheral cannabinoid receptor Cb2, a novel oncoprotein, induces a reversible block in neutrophilic differentiation
Blood,
February 15, 2003;
101(4):
1336 - 1343.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Maccarrone, M. Bari, N. Battista, and A. Finazzi-Agro
Estrogen stimulates arachidonoylethanolamide release from human endothelial cells and platelet activation
Blood,
December 1, 2002;
100(12):
4040 - 4048.
[Abstract]
[Full Text]
[PDF]
|
 |
|
|
|